Krsnaa Diagnostics Limited — Investor Meet, 20-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

1. **Financial Performance**: Krsnaa Diagnostics reported revenue of INR 1,745 million for Q3 FY25, reflecting a 10% year-on-year increase. EBITDA stood at INR 466 million with a robust margin of 27%, and profit reached INR 194 million, marking a significant 50% growth year-on-year. For the first nine months, revenues totaled INR 5,311 million, up 17% from the previous year, with EBITDA rising 39% to INR 1,416 million. Notably, net profit also surged by 49% to INR 569 million, and the diluted EPS increased to INR 17.26.

2. **Future Outlook and Growth Drivers**: Management reiterated optimism, citing strong demand for diagnostics and new initiatives linked to the recent budget, which prioritizes healthcare. The company plans to capitalize on government initiatives, particularly in public-private partnerships (PPP), and has launched new retail operations in four states, leveraging existing infrastructure to enhance market penetration.

3. **Order Book and Operational Updates**: The implementation of new centers is set to resume, with management targeting six centers operational in Q4. Additionally, 40 CT scan machines have been commissioned in Maharashtra, with further installations planned. Recent agreements in Jharkhand will facilitate two new centers expected by Q1 FY26.

4. **Analyst Q&A Insights**:

- **Revenue and Profitability**: Analysts queried about the impact of operational delays on expected revenue; management emphasized that moderation was temporary and growth in Q4 is anticipated.

- **Market Position and Competitive Landscape**: Discussions highlighted the growing demand in both pathology and radiology, with management confident of maintaining competitive pricing and quality.

- **Operational Challenges or Risks**: The company acknowledged receivables delays in Himachal Pradesh and Karnataka but expressed optimism regarding collection normalization by year-end.

- **Capex and Capital Allocation**: Management noted a strategic focus on an asset-light model, particularly in the retail segment, which limits capital expenditure while encouraging scalability.

- **Strategic Priorities and Long-Term Vision**: Analysts noted Krsnaa's focus on integrating digital solutions and enhancing health service accessibility, aligning with broader market trends.

5. **Market or Regulatory Updates**: The recent budget emphasized health care funding, particularly through PPP models, positively impacting Krsnaa’s operational environment and future growth potential.

6. **Strategic Focus Areas**: The dialogues emphasized a commitment to expanding both retail and B2B services, enhancing operational efficiencies through AI and technology, and improving workforce capabilities via training initiatives.

7. **Investor Insight**: Given Krsnaa Diagnostics' solid financial growth, strategic initiatives in retail and operational efficiencies alongside government support for healthcare, the company presents a favorable outlook for investors. The current financial trajectory and growth potential suggest a favorable position, aligning with a ‘buy’ stance.